Top 10 Key Players companies in PCSK9 Inhibitors by Most News Heat in the Japan in 2022 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat PCSK9 Inhibitors Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Daiichi Sankyo Co., Ltd.	New Jersey, Japan	Clinical trial,Cardiovascular agent,Drug, ...[+2]	news: 8
2	Takeda Pharmaceutical Co., Ltd.	Osaka, Japan	Medicine,Health care,Clinical trial, ...[+2]	news: 7
3	Daiichi Koutsu Sangyo Co., Ltd.	Fukuoka, Japan	Glatiramer acetate,Rotigotine,Interferon beta, ...[+2]	news: 4
4	EPS Holdings, Inc.	Tokyo, Japan	Clinical trial,Health care,Data processing, ...[+2]	news: 4
5	Astellas Pharma, Inc.	Tokyo, Japan	Health care,Clinical trial,Diabetic complication, ...[+2]	news: 3
6	Eisai Co., Ltd.	Tokyo, Japan	Health care,Over-the-counter,Clinical trial, ...[+2]	news: 3
7	Kyowa Kirin Co., Ltd.	Tokyo, Japan	Health care,Drug,Medicine, ...[+2]	news: 3
8	UT Group Co., Ltd.	Tokyo, Japan	Airplane,Software outsourcing,Semiconductor, ...[+1]	news: 2
9	Kowa Co., Ltd.	Aichi, Japan	Medicine,Medical equipment,Textile, ...[+2]	news: 2
10	B-Lot Co. Ltd.	Tokyo, Japan	Investment strategy,Compression therapy,Construction management, ...[+2]	news: 2